NASDAQ
Insight Molecular Diagnostics Inc. (IMDX) has a price/sales ratio of 56.37x as of Friday, May 22, 2026. This represents a 46.24% increase compared to its 12-month average of 38.54x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.
No price data available for this timeframe.